Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia

NCT05280093 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT05280093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05280093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia
Lead sponsor
AtriCure, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 31, 2022
Completion date
February 29, 2028
Enrollment
142 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

inappropriate sinus tachycardia